Quantitative evaluation of pigment epithelial encapsulation using polarization-sensitive optical coherence tomography after anti-VEGF therapy for myopic choroidal neovascularization.
{"title":"Quantitative evaluation of pigment epithelial encapsulation using polarization-sensitive optical coherence tomography after anti-VEGF therapy for myopic choroidal neovascularization.","authors":"Mami Ota, Yuki Saeki, Kazuki Yashiro, Shuichiro Aoki, Kohdai Kitamoto, Ryo Terao, Keiko Azuma","doi":"10.1186/s40942-026-00902-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to investigate the association between post-treatment changes in polarimetric entropy (PE), which is a noninvasive surrogate marker of structural heterogeneity associated with pigment epithelial remodeling and measured by polarization-sensitive optical coherence tomography (PS-OCT), and the need for multiple anti-vascular endothelial growth factor (VEGF)-injections in myopic choroidal neovascularization (mCNV).</p><p><strong>Methods: </strong>We retrospectively analyzed 11 eyes that received intra-vitreal anti-VEGF injections for treatment-naïve mCNV. Based on treatment response during the first 3 months, eyes were categorized into the single-injection (n = 9) and multiple-injection (n = 2) groups. PS-OCT en face PE maps (6 × 6 mm) were obtained at baseline and 3 months after treatment, with the analysis area manually centered over the CNV using a 3-mm Early Treatment Diabetic Retinopathy Study (ETDRS) grid. PE values were extracted from the central 1-mm circle (CNV core) and surrounding 1-3-mm annulus (periphery), and the differences before and after treatment were calculated. Intergroup comparisons were conducted using Wilcoxon rank-sum test.</p><p><strong>Results: </strong>PE within the CNV core increased after treatment (p = 0.0037). The multiple-injection group showed a greater PE increase than the single-injection group (p = 0.0347), although this finding should be interpreted cautiously given the small and imbalanced sample size. Exploratory analysis suggested a positive association between the magnitude of PE change in the CNV core and injection number during the 3-month period.</p><p><strong>Conclusions: </strong>High post-treatment entropy may reflect structural heterogeneity associated with pigment epithelial remodeling during the early healing phase. These findings suggest that PS-OCT entropy imaging may serve as a retrospective indicator of tissue response rather than a predictive biomarker in the present dataset. Given the very small and imbalanced sample size, the results should be interpreted as exploratory and hypothesis-generating.</p>","PeriodicalId":14289,"journal":{"name":"International Journal of Retina and Vitreous","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13651188/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Retina and Vitreous","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40942-026-00902-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: We aimed to investigate the association between post-treatment changes in polarimetric entropy (PE), which is a noninvasive surrogate marker of structural heterogeneity associated with pigment epithelial remodeling and measured by polarization-sensitive optical coherence tomography (PS-OCT), and the need for multiple anti-vascular endothelial growth factor (VEGF)-injections in myopic choroidal neovascularization (mCNV).
Methods: We retrospectively analyzed 11 eyes that received intra-vitreal anti-VEGF injections for treatment-naïve mCNV. Based on treatment response during the first 3 months, eyes were categorized into the single-injection (n = 9) and multiple-injection (n = 2) groups. PS-OCT en face PE maps (6 × 6 mm) were obtained at baseline and 3 months after treatment, with the analysis area manually centered over the CNV using a 3-mm Early Treatment Diabetic Retinopathy Study (ETDRS) grid. PE values were extracted from the central 1-mm circle (CNV core) and surrounding 1-3-mm annulus (periphery), and the differences before and after treatment were calculated. Intergroup comparisons were conducted using Wilcoxon rank-sum test.
Results: PE within the CNV core increased after treatment (p = 0.0037). The multiple-injection group showed a greater PE increase than the single-injection group (p = 0.0347), although this finding should be interpreted cautiously given the small and imbalanced sample size. Exploratory analysis suggested a positive association between the magnitude of PE change in the CNV core and injection number during the 3-month period.
Conclusions: High post-treatment entropy may reflect structural heterogeneity associated with pigment epithelial remodeling during the early healing phase. These findings suggest that PS-OCT entropy imaging may serve as a retrospective indicator of tissue response rather than a predictive biomarker in the present dataset. Given the very small and imbalanced sample size, the results should be interpreted as exploratory and hypothesis-generating.
期刊介绍:
International Journal of Retina and Vitreous focuses on the ophthalmic subspecialty of vitreoretinal disorders. The journal presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice. Topical areas include, but are not limited to: -Imaging of the retina, choroid and vitreous -Innovations in optical coherence tomography (OCT) -Small-gauge vitrectomy, retinal detachment, chromovitrectomy -Electroretinography (ERG), microperimetry, other functional tests -Intraocular tumors -Retinal pharmacotherapy & drug delivery -Diabetic retinopathy & other vascular diseases -Age-related macular degeneration (AMD) & other macular entities